Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacturing	494.13M	600.35M	644.41M	619.23M	471.79M
Manufacturing Growth	-17.69%	-6.84%	4.07%	31.25%	96.84%
Marketing	473.89M	427.53M	420.23M	414.15M	383.98M
Marketing Growth	10.84%	1.74%	1.47%	7.86%	-17.20%
Other	99.00K	-	-	-	-
Inter-Segment Transactions	-224.63M	-264.13M	-235.13M	-215.69M	-207.09M
Total	743.48M	763.75M	829.51M	817.70M	648.68M
Total Growth	-2.65%	-7.93%	1.44%	26.06%	54.46%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Spain	285.35M	277.01M	273.36M	264.27M	256.70M
Spain Growth	3.01%	1.34%	3.44%	2.95%	12.18%
European Union	174.29M	146.11M	143.65M	136.55M	119.63M
European Union Growth	19.29%	1.71%	5.20%	14.14%	-5.96%
OECD Countries	241.59M	304.76M	380.88M	376.76M	243.56M
OECD Countries Growth	-20.73%	-19.99%	1.09%	54.69%	392.66%
Other Countries	42.25M	35.87M	31.63M	40.12M	28.79M
Other Countries Growth	17.79%	13.42%	-21.18%	39.36%	98.67%
Total	743.48M	763.75M	829.51M	817.70M	648.68M
Total Growth	-2.65%	-7.93%	1.44%	26.06%	54.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error